Ad is loading...
FTAEX
Price
$11.64
Change
-$0.08 (-0.68%)
Updated
Nov 15 closing price
VTSNX
Price
$129.61
Change
-$0.62 (-0.48%)
Updated
Nov 15 closing price
Ad is loading...

FTAEX vs VTSNX

Header iconFTAEX vs VTSNX Comparison
Open Charts FTAEX vs VTSNXBanner chart's image
Fidelity Advisor Total Intl Equity A
Price$11.64
Change-$0.08 (-0.68%)
VolumeN/A
CapitalizationN/A
Vanguard Total Intl Stock Index I
Price$129.61
Change-$0.62 (-0.48%)
VolumeN/A
CapitalizationN/A
FTAEX vs VTSNX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FTAEX vs. VTSNX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FTAEX is a Buy and VTSNX is a Buy.

FUNDAMENTALS
Fundamentals
VTSNX has more cash in the bank: 442B vs. FTAEX (319M). VTSNX pays higher dividends than FTAEX: VTSNX (3.29) vs FTAEX (1.02). FTAEX was incepted earlier than VTSNX: FTAEX (17 years) vs VTSNX (14 years). FTAEX is a more actively managed with annual turnover of: 28.00 vs. VTSNX (4.00). FTAEX has a lower initial minimum investment than VTSNX: FTAEX (0) vs VTSNX (5000000). FTAEX annual gain was more profitable for investors over the last year : 15.19 vs. VTSNX (10.92). FTAEX return over 5 years is better than : 29.20 vs. VTSNX (15.91).
FTAEXVTSNXFTAEX / VTSNX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence17 years14 years-
Gain YTD7.6784.535169%
Front LoadN/AN/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets319M442B0%
Annual Yield % from dividends1.023.2931%
Returns for 1 year15.1910.92139%
Returns for 3 years-4.84-5.8683%
Returns for 5 years29.2015.91183%
Returns for 10 years62.6929.81210%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CLSK14.030.05
+0.36%
CleanSpark
BSRR31.33-0.19
-0.60%
Sierra Bancorp
GEHC81.76-1.16
-1.40%
GE HealthCare Technologies
NXTC1.31-0.03
-2.24%
NextCure
RCKT13.98-0.84
-5.67%
Rocket Pharmaceuticals